|
2025
|
Invention
|
Use of the il-6 inhibitor olokizumab for the treatment of progressive fibrotic interstitial lung ... |
|
2024
|
Invention
|
Use of il1-r1 derived inhibitor of il-1b for the treatment of idiopathic recurrent pericarditis. ... |
|
2021
|
Invention
|
Tgf-β inhibitor composition and use thereof. A therapeutic composition is described that can be u... |
|
|
Invention
|
Il1-r1 derived inhibitor of il-1β and use thereof. A therapeutic composition is described that ca... |
|
|
Invention
|
Ace2-derived composition and use thereof. |
|
2020
|
Invention
|
Il1-r1 derived inhibitor of il-1b and use thereof. A therapeutic composition is described that ca... |
|
2018
|
Invention
|
Anti-pd-l1 antibody and use thereof.
Fully human anti-PD-L1 antibodies and their corresponding a... |
|
|
Invention
|
Anti-pd-l1 antibody and use thereof. Disclosed are fully human anti-PD-Ll antibodies and their co... |
|
2015
|
Invention
|
Substituted 2-thioxo-imidazolidin-4-ones and spiro analogues thereof, active anticancer ingredien... |
|
|
Invention
|
Pd-l1 antagonist fully human antibody. A antibody is described that can be used for treating or p... |
|
2014
|
Invention
|
Antibodies against human receptor integrin alpha-4. Therapeutic antibodies are described that can... |
|
|
Invention
|
Fully human antibodies against human receptor integrin alpha-4. Therapeutic antibodies are descri... |
|
|
Invention
|
Human il1-r1 derived inhibitor of il-1β. A therapeutic composition is described that can be used ... |
|
|
Invention
|
Human il 1-r1 derived inhibitor of il-1b. A therapeutic composition is described that can be used... |
|
|
Invention
|
B7 ligands/cd20 inhibitor composition and use thereof. A therapeutic composition is described tha... |
|
|
Invention
|
Osteoprotegerin derived rankl inhibitor.
A pharmaceutical composition is described that can be u... |
|
|
Invention
|
Osteoprotegerin derived rankl inhibitor. A pharmaceutical composition is described that can be us... |
|
2013
|
Invention
|
Fully human antibodies against human rankl. Therapeutic antibodies are described that can be used... |
|
|
Invention
|
Cyclic n,n′-diarylthiourea—androgen receptor antagonist, anti breast cancer composition and use t... |
|
2011
|
Invention
|
Cyclic n,n′-diarylthioureas and n,n′-diarylureas-androgen receptor antagonists, anticancer agent,... |
